April 01, 2025

GEM Helps Put T2D in Remission

Researchers highlight evidence-based lifestyle and pharmacologic strategies, including glycemic excursion minimization and tirzepatide, for early glycemic control in adults with type 2 diabetes.

Conexiant

April 01, 2025

Medical Oddities: Shrinking Brains, Failing Hearts?

Brains shrink, bots soothe, tea disappoints, and love gets the hormonal spotlight it deserves this week.

Conexiant

March 31, 2025

Tariff Threat: Drugs Could Cost U.S. $750M More

New research reveals 25% tariffs on Canadian pharmaceuticals would impact critical medications, strain supply chains, and potentially increase costs—with 28 drugs having no alternative suppliers.

Conexiant

March 31, 2025

Cold Plunges: A Cellular Reset?

New research shows that 1 week of daily cold-water immersion enhances autophagy and reduces cell death signals.

Conexiant

March 31, 2025

Persistent PSA Associated with Survival Risk

PSA level assessed for at least 3 months postoperatively may minimize overtreatment, according to a recent study.

Conexiant

March 28, 2025

FDA Clears First OTC Multi-STI Test

The diagnostic test for chlamydia, gonorrhea, and trichomoniasis offers 30-minute results.

Conexiant

March 27, 2025

Does Religion Protect Mental Health?

Study reveals that religiousness is linked to lower depression rates among U.S. college students, with significant variations based on sexual orientation and religious affiliation.

Conexiant

March 27, 2025

Medical Oddities: Metabolism’s Secret Sugar-Burning Switch

Science served weird this week: sleepy seniors, sneaky genes, and memory-hacking babies.

Conexiant

March 27, 2025

Simplified Tesamorelin Option for HIV Lipodystrophy

EGRIFTA WR™ has received FDA approval for use in adults with HIV and lipodystrophy to reduce excess abdominal fat with once-weekly reconstitution and a lower injection volume.

Conexiant